Search research articles
Contact Us
Filters
Showing results (21-30 of 158) with videos related to
Page
of 16
Sort By:
JACC. Heart Failure
|
March 9, 2023
Redefining Pre-Heart Failure With Cardiac Biomarkers: Clinical and Research Implications
Palak Shah, Rafael Arias, Christopher R deFilippi
Circulation
|
October 16, 2020
Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician
Palak Shah, Christopher R deFilippi, Kristin E Mullins
Circulation
|
July 18, 2018
Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction
James McCord, L Kristin Newby, Christopher R deFilippi
Coronary Artery Disease
|
October 17, 2013
Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond
Christopher End, Stephen L Seliger, Christopher R deFilippi
Circulation
|
January 22, 2019
Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction"
James McCord, L Kristin Newby, Christopher R deFilippi
Annals of Emergency Medicine
|
October 24, 2020
In reply
Richard M Nowak, William F Peacock, Christopher R deFilippi
Clinical Biochemistry
|
January 25, 2015
Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction
Ravi H Parikh, Stephen L Seliger, Christopher R deFilippi
Clinical Chemistry
|
April 8, 2011
Highly sensitive troponin assays and the cardiology community: a love/hate relationship?
James A de Lemos, David A Morrow, Christopher R deFilippi
Clinical Chemistry
|
June 26, 2007
Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality
Christopher R deFilippi, Stephen L Seliger, Susan Maynard, et al.
The American Journal of Cardiology
|
February 11, 2015
Soluble ST2 testing in the general population
Jennifer E Ho, Piyamitr Sritara, Christopher R deFilippi, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 158) with videos related to
Sort By:
Page
of 16
JACC. Heart Failure
|
March 9, 2023
Redefining Pre-Heart Failure With Cardiac Biomarkers: Clinical and Research Implications
Palak Shah, Rafael Arias, Christopher R deFilippi
Circulation
|
October 16, 2020
Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician
Palak Shah, Christopher R deFilippi, Kristin E Mullins
Circulation
|
July 18, 2018
Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction
James McCord, L Kristin Newby, Christopher R deFilippi
Coronary Artery Disease
|
October 17, 2013
Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond
Christopher End, Stephen L Seliger, Christopher R deFilippi
Circulation
|
January 22, 2019
Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction"
James McCord, L Kristin Newby, Christopher R deFilippi
Annals of Emergency Medicine
|
October 24, 2020
In reply
Richard M Nowak, William F Peacock, Christopher R deFilippi
Clinical Biochemistry
|
January 25, 2015
Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction
Ravi H Parikh, Stephen L Seliger, Christopher R deFilippi
Clinical Chemistry
|
April 8, 2011
Highly sensitive troponin assays and the cardiology community: a love/hate relationship?
James A de Lemos, David A Morrow, Christopher R deFilippi
Clinical Chemistry
|
June 26, 2007
Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality
Christopher R deFilippi, Stephen L Seliger, Susan Maynard, et al.
The American Journal of Cardiology
|
February 11, 2015
Soluble ST2 testing in the general population
Jennifer E Ho, Piyamitr Sritara, Christopher R deFilippi, et al.
Page
of 16